{"SPADE_UN_08054": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 6884776 B1", "Patent Link": "http://www.lens.org/lens/patent/US_6884776_B1", "Patent Type": "Granted Patent", "Publication Date": "2005-4-26", "Family Info": "CA2291894A1,DE69840024D1,EP1003854A1,EP1003854B1,WO1998054314A1", "Patent Title": "Antimicrobial peptides derived from ubiquicidine.", "Abstract": "The invention relates to the use of ubiquicidine or optionally modified peptide fragments derived therefrom for the preparation of a drug for the treatment, diagnostics or prophylaxis of infections in humans and animals. A peptide fragment derived from ubiquicidine comprises for instance a preferably continuous series of at least 3, preferably at least 7-13 amino acids from the amino acid sequence of ubiquicidine."}], "Sequence Information": {"SPADE ID": "SPADE_UN_08054", "Sequence": "KVAKQEKKKKKTGRAKRR", "Sequence Length": 18, "Peptide Name": "Sequence 5 from Patent US 6884776", "Source": "Synthetic construct", "Biological Activity": ["Antimicrobial"], "Frequent Amino Acids": "KRA", "Absent Amino Acids": "CDFHILMNOPSUWY", "Basic Residues": 11, "Acidic Residues": 1, "Hydrophobic Residues": 3, "Polar Residues": 16, "Positive Residues": 11, "Negative Residues": 1, "Mass": 2168.64, "PI": 11.78, "Net Charge": 10, "Hydrophobicity": -2.5, "Similar Sequences": [{"SPADE_ID": "SPADE_N_15595", "Similarity": 1.0, "Sequence": "KVHGSLARAGKVRGQTPKVAKQEKKKKKTGRAKRRMQYNRRFVNVVPTFGKKKGPNANS"}, {"SPADE_ID": "SPADE_UN_08053", "Similarity": 1.0, "Sequence": "KVAKQEKKKKKT"}, {"SPADE_ID": "SPADE_UN_08055", "Similarity": 1.0, "Sequence": "AKVAKQEKKKKKTGRAKRRA"}]}}}